These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17336390)

  • 41. Actions of estrogens on glial cells: Implications for neuroprotection.
    Arevalo MA; Santos-Galindo M; Bellini MJ; Azcoitia I; Garcia-Segura LM
    Biochim Biophys Acta; 2010 Oct; 1800(10):1106-12. PubMed ID: 19818384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione.
    Green PS; Gridley KE; Simpkins JW
    Neuroscience; 1998 May; 84(1):7-10. PubMed ID: 9522357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.
    Manavathi B; Kumar R
    J Cell Physiol; 2006 Jun; 207(3):594-604. PubMed ID: 16270355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental Procedures for Demonstration of MicroRNA Mediated Enhancement of Functional Neuroprotective Effects of Estrogen Receptor Agonists.
    Chakrabarti M; Ray SK
    Methods Mol Biol; 2016; 1366():359-372. PubMed ID: 26585150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.
    Bourque M; Dluzen DE; Di Paolo T
    Front Neuroendocrinol; 2012 Apr; 33(2):169-78. PubMed ID: 22387674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sex hormones, neuroprotection and cognition.
    Behl C
    Prog Brain Res; 2002; 138():135-42. PubMed ID: 12432767
    [No Abstract]   [Full Text] [Related]  

  • 47. Estrogen protects against dopamine neuron toxicity in primary mesencephalic cultures through an indirect P13K/Akt mediated astrocyte pathway.
    Bains M; Roberts JL
    Neurosci Lett; 2016 Jan; 610():79-85. PubMed ID: 26520464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Astrocytes Mediate Protective Actions of Estrogenic Compounds after Traumatic Brain Injury.
    Martin-Jiménez C; Gaitán-Vaca DM; Areiza N; Echeverria V; Ashraf GM; González J; Sahebkar A; Garcia-Segura LM; Barreto GE
    Neuroendocrinology; 2019; 108(2):142-160. PubMed ID: 30391959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection.
    Garcia-Segura LM; Cardona-Gómez GP; Chowen JA; Azcoitia I
    J Neurocytol; 2000; 29(5-6):425-37. PubMed ID: 11424959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogens as neuroprotectants against ischemic stroke.
    Alonso de Leciñana M; Egido JA
    Cerebrovasc Dis; 2006; 21 Suppl 2():48-53. PubMed ID: 16651814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Potential Effects of Phytoestrogens: The Role in Neuroprotection.
    Gorzkiewicz J; Bartosz G; Sadowska-Bartosz I
    Molecules; 2021 May; 26(10):. PubMed ID: 34065647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane cholesterol as a mediator of the neuroprotective effects of estrogens.
    Peri A; Benvenuti S; Luciani P; Deledda C; Cellai I
    Neuroscience; 2011 Sep; 191():107-17. PubMed ID: 21396986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The assessment of non-feminizing estrogens for use in neuroprotection.
    Yi KD; Perez E; Yang S; Liu R; Covey DF; Simpkins JW
    Brain Res; 2011 Mar; 1379():61-70. PubMed ID: 21111714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen and ischemic neuroprotection: an integrated view.
    McCullough LD; Hurn PD
    Trends Endocrinol Metab; 2003 Jul; 14(5):228-35. PubMed ID: 12826329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroprotective effect of estrogen: role of nonsynaptic NR2B-containing NMDA receptors.
    Liu SB; Zhao MG
    Brain Res Bull; 2013 Apr; 93():27-31. PubMed ID: 23085545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotective effects of phenolic A ring oestrogens.
    Green PS; Yang SH; Simpkins JW
    Novartis Found Symp; 2000; 230():202-13; discussion 213-20. PubMed ID: 10965510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oestrogen receptor subtype-specific repression of calpain expression and calpain enzymatic activity in neuronal cells--implications for neuroprotection against Ca-mediated excitotoxicity.
    Gamerdinger M; Manthey D; Behl C
    J Neurochem; 2006 Apr; 97(1):57-68. PubMed ID: 16524385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogens: neuroprotective or neurotoxic?
    Scallet AC
    Ann N Y Acad Sci; 1999; 890():121-32. PubMed ID: 10668420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues.
    Watson CS; Alyea RA; Jeng YJ; Kochukov MY
    Mol Cell Endocrinol; 2007 Aug; 274(1-2):1-7. PubMed ID: 17601655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen and Alzheimer's disease.
    LeBlanc A
    Curr Opin Investig Drugs; 2002 May; 3(5):768-73. PubMed ID: 12090551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.